Trial intelligence / Profile preview

Vitamin D supplementation for COPD exacerbation prevention

NCT02122627Completed

Sponsor
Amsterdam University Medical Center
Start
Apr 2015
Primary completion
Jun 2019
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Vitamin D with Placebo (2 arms). Primary endpoint: Exacerbation rate at 1 year. Started Apr 2015; status: completed.

02

Drugs

cholecalciferol
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NCT02122627.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02122627.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call